{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:00:40Z","timestamp":1793224840345,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:00Z","timestamp":1426377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00467-014-3041-y","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T20:44:00Z","timestamp":1426365840000},"page":"1121-1129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children"],"prefix":"10.1007","volume":"30","author":[{"given":"Zhijuan","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuirong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"3041_CR1","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","volume":"18","author":"HN Reich","year":"2007","unstructured":"Reich HN, Troyanov S, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry (2007) Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 18:3177\u20133183","journal-title":"J Am Soc Nephrol"},{"key":"3041_CR2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347:738\u2013748","journal-title":"N Engl J Med"},{"key":"3041_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1681\/ASN.V82199","volume":"8","author":"MG Radford Jr","year":"1997","unstructured":"Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP (1997) Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8:199\u2013207","journal-title":"J Am Soc Nephrol"},{"key":"3041_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1440-1797.2004.00255.x","volume":"9","author":"JA Samuels","year":"2004","unstructured":"Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA (2004) Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology (Carlton) 9:177\u2013185","journal-title":"Nephrology (Carlton)"},{"key":"3041_CR5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s004670100582","volume":"16","author":"N Yoshikawa","year":"2001","unstructured":"Yoshikawa N, Tanaka R, Iijima K (2001) Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 16:446\u2013457","journal-title":"Pediatr Nephrol"},{"key":"3041_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","volume":"24","author":"G D\u2019Amico","year":"2004","unstructured":"D\u2019Amico G (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24:179\u2013196","journal-title":"Semin Nephrol"},{"key":"3041_CR7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1681\/ASN.2010040355","volume":"22","author":"F Berthoux","year":"2011","unstructured":"Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L (2011) Predicting the risk of dialysis or death in IgA nephropathy. J Am Soc Nephrol 22:752\u2013761","journal-title":"J Am Soc Nephrol"},{"key":"3041_CR8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5414\/CPP48509","volume":"48","author":"XW Liu","year":"2010","unstructured":"Liu XW, Li DM, Xu GS, Sun SR (2010) Comparison of therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome. Int J Clin Pharmacol Ther 48:509\u2013513","journal-title":"Int J Clin Pharmacol Ther"},{"key":"3041_CR9","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ndt\/gfq559","volume":"26","author":"SH Han","year":"2011","unstructured":"Han SH, Kang EW, Park JK, Kie JH, Han DS, Kang SW (2011) Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy. Nephrol Dial Transplant 26:1570\u20131575","journal-title":"Nephrol Dial Transplant"},{"key":"3041_CR10","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.3346\/jkms.2009.24.S1.S44","volume":"24","author":"SM Kim","year":"2009","unstructured":"Kim SM, Moon KC, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S (2009) Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome. J Korean Med Sci 24:S44\u2013S49","journal-title":"J Korean Med Sci"},{"key":"3041_CR11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.17305\/bjbms.2008.2923","volume":"8","author":"S Rasi\u0107","year":"2008","unstructured":"Rasi\u0107 S, Uncanin S, Aganovi\u0107 K, Rasi\u0107 I, Dzemidzi\u0107 J, Muslimovi\u0107 A (2008) Treatment of IgA nephropathy of adults presented by nephrotic syndrome. Bosn J Basic Med Sci 8:230\u2013233","journal-title":"Bosn J Basic Med Sci"},{"key":"3041_CR12","first-page":"79","volume":"55","author":"D Maksi\u0107","year":"1998","unstructured":"Maksi\u0107 D, Mari\u0107 M, Dimitrijevi\u0107 J, Kovacevi\u0107 Z, Hrvacevi\u0107 R, Jovanovi\u0107 D, Ignjatovi\u0107 L, Veljanci\u0107 L (1998) Treatment of IgA nephropathy with nephrotic syndrome using pulse doses of IgG. Vojnosanit Pregl 55:79\u201384","journal-title":"Vojnosanit Pregl"},{"key":"3041_CR13","first-page":"247","volume":"30","author":"K Fukushi","year":"1988","unstructured":"Fukushi K, Yamabe H, Ozawa K, Kubota H, Osawa H, Chiba N, Onodera K, Oike Y (1988) Clinicopathological evaluation of IgA nephropathy associated with nephrotic syndrome. Nihon Jinzo Gakkai Shi 30:247\u2013251","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"3041_CR14","first-page":"174","volume":"26","author":"KN Lai","year":"1986","unstructured":"Lai KN, Kai FM, Ho CP, Chan KW (1986) Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol 26:174\u2013180","journal-title":"Clin Nephrol"},{"key":"3041_CR15","first-page":"677","volume":"57","author":"KN Lai","year":"1985","unstructured":"Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J (1985) Nephrotic range proteinuria\u2014a good predictive index of disease in IgA nephropathy? Q J Med 57:677\u2013678","journal-title":"Q J Med"},{"key":"3041_CR16","first-page":"172","volume":"20","author":"J Mustonen","year":"1983","unstructured":"Mustonen J, Pasternack P, Rantala I (1983) The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy. Clin Nephrol 20:172\u2013176","journal-title":"Clin Nephrol"},{"key":"3041_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2215\/CJN.04820511","volume":"7","author":"JK Kim","year":"2012","unstructured":"Kim JK, Kim JH, Lee SC, Kang EW, Chang TI, Moon SJ, Yoon SY, Yoo TH, Kang SW, Choi KH, Han DS, Kie JH, Lim BJ, Jeong HJ, Han SH (2012) Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol 7:427\u2013436","journal-title":"Clin J Am Soc Nephrol"},{"key":"3041_CR18","first-page":"486","volume":"51","author":"Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases","year":"2013","unstructured":"Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases (2013) Multicenter investigation of therapeutic status of children with IgA nephropathy in China. Zhonghua Er Ke Za Zhi 51:486\u2013490","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"3041_CR19","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/ndt\/gfp091","volume":"24","author":"JH Chang","year":"2009","unstructured":"Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Kang SW, Choi KH, Han DS, Jeong HJ, Lee HY (2009) Changing prevalence of glomerular diseases in Korean adults: a review of 20\u00a0years of experience. Nephrol Dial Transplant 24:2406\u20132410","journal-title":"Nephrol Dial Transplant"},{"key":"3041_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000168050","volume":"10","author":"DM Clive","year":"1990","unstructured":"Clive DM, Galvanek EG, Silva FG (1990) Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome: a report of an older patient and review of the literature. Am J Nephrol 10:31\u201336","journal-title":"Am J Nephrol"},{"key":"3041_CR21","first-page":"205","volume":"6","author":"A Furuse","year":"1985","unstructured":"Furuse A, Hiramatsu M, Adachi N, Karashima S, Hattori S, Matsuda I (1985) Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy. Int J Pediatr Nephrol 6:205\u2013208","journal-title":"Int J Pediatr Nephrol"},{"key":"3041_CR22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2215\/CJN.08630910","volume":"6","author":"K Kamei","year":"2011","unstructured":"Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group (2011) Long-term results of a randomized controlled trial in childhood IgA nephropathy. Clin J Am Soc Nephrol 6:1301\u20131307","journal-title":"Clin J Am Soc Nephrol"},{"key":"3041_CR23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","volume":"98","author":"International Study of Kidney Disease in Children","year":"1981","unstructured":"International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561\u2013564","journal-title":"J Pediatr"},{"key":"3041_CR24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society","year":"2009","unstructured":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) the Oxford Classification of IgA Nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534\u2013545","journal-title":"Kidney Int"},{"key":"3041_CR25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","volume":"76","author":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society","year":"2009","unstructured":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) the Oxford Classification of IgA Nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546\u2013556","journal-title":"Kidney Int"},{"key":"3041_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:179\u2013184","journal-title":"Nephron Clin Pract"},{"key":"3041_CR27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1797.2007.00898.x","volume":"13","author":"J Lv","year":"2008","unstructured":"Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H (2008) Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrology (Carlton) 13:242\u2013246","journal-title":"Nephrology (Carlton)"},{"key":"3041_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/ajkd.2000.8966","volume":"36","author":"G D\u2019Amico","year":"2000","unstructured":"D\u2019Amico G (2000) Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 36:227\u2013237","journal-title":"Am J Kidney Dis"},{"key":"3041_CR29","first-page":"242","volume":"66","author":"P Shen","year":"2008","unstructured":"Shen P, He L, Huang D (2008) Clinical course and prognostic factors of clinically early IgA nephropathy. Neth J Med 66:242\u2013247","journal-title":"Neth J Med"},{"key":"3041_CR30","volume":"3","author":"S Reid","year":"2011","unstructured":"Reid S, Cawthon PM, Craig JC, Samuels JA, Molony DA, Strippoli GF (2011) Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database Syst Rev 3:CD003962","journal-title":"Cochrane Database Syst Rev"},{"key":"3041_CR31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s10157-008-0036-7","volume":"12","author":"M Koike","year":"2008","unstructured":"Koike M, Takei T, Uchida K, Honda K, Moriyama T, Horita S, Ogawa T, Yoshida T, Tsuchiya K, Nitta K (2008) Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center. Clin Exp Nephrol 12:250\u2013255","journal-title":"Clin Exp Nephrol"},{"key":"3041_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ajkd.2008.07.029","volume":"53","author":"J Lv","year":"2009","unstructured":"Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H (2009) Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 53:26\u201332","journal-title":"Am J Kidney Dis"},{"key":"3041_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000422413","volume":"104","author":"BA Julian","year":"1993","unstructured":"Julian BA, Barker C (1993) Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial. Contrib Nephrol 104:198\u2013206","journal-title":"Contrib Nephrol"},{"key":"3041_CR34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0272-6386(00)70326-X","volume":"35","author":"T Shoji","year":"2000","unstructured":"Shoji T, Nakanishi I, Suzuki A, Hayashi T, Togawa M, Okada N, Imai E, Hori M, Tsubakihara Y (2000) Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis 35:194\u2013201","journal-title":"Am J Kidney Dis"},{"key":"3041_CR35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","volume":"353","author":"C Pozzi","year":"1999","unstructured":"Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F (1999) Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353:883\u2013887","journal-title":"Lancet"},{"key":"3041_CR36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","volume":"15","author":"C Pozzi","year":"2004","unstructured":"Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15:157\u2013163","journal-title":"J Am Soc Nephrol"},{"key":"3041_CR37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3349\/ymj.1990.31.3.258","volume":"31","author":"J Choi","year":"1990","unstructured":"Choi J, Jeong HJ, Lee HY, Kim PK, Lee JS, Han DS (1990) Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases. Yonsei Med J 31:258\u2013263","journal-title":"Yonsei Med J"},{"key":"3041_CR38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3349\/ymj.1992.33.4.351","volume":"33","author":"HJ Jeong","year":"1992","unstructured":"Jeong HJ, Jung SH, Choi IJ (1992) Electron microscopic study of the cases of minimal change nephrotic syndrome with mesangial IgA deposition. Yonsei Med J 33:351\u2013356","journal-title":"Yonsei Med J"},{"key":"3041_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","volume":"136","author":"AC Allison","year":"1993","unstructured":"Allison AC, Eugui EM (1993) Immunosuppressive and other effects of mycophenolic acid ester prodrug, mycophenolate mofetil. Immunol Rev 136:5\u201328","journal-title":"Immunol Rev"},{"key":"3041_CR40","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00467-009-1375-7","volume":"25","author":"Z Li","year":"2010","unstructured":"Li Z, Duan C, He J, Wu T, Xun M, Zhang Y, Yin Y (2010) Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 25:883\u2013888","journal-title":"Pediatr Nephrol"},{"key":"3041_CR41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1442-200X.2007.02487.x","volume":"49","author":"M Okada","year":"2007","unstructured":"Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T (2007) Mycophenolate mofetil therapy for children with intractable nephrotic syndrome. Pediatr Int 49:933\u2013937","journal-title":"Pediatr Int"},{"key":"3041_CR42","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00467-005-1964-z","volume":"20","author":"A Moudgil","year":"2005","unstructured":"Moudgil A, Bagga A, Jordan SC (2005) Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. Pediatr Nephrol 20:1376\u20131381","journal-title":"Pediatr Nephrol"},{"key":"3041_CR43","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00467-005-1957-y","volume":"20","author":"I Novak","year":"2005","unstructured":"Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H (2005) Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 20:1265\u20131268","journal-title":"Pediatr Nephrol"},{"key":"3041_CR44","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00467-005-1877-x","volume":"20","author":"S Mendiz\u00e1bal","year":"2005","unstructured":"Mendiz\u00e1bal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J (2005) Mycophenolate mofetil in steroid\/cyclosporine-dependent\/resistant nephrotic syndrome. Pediatr Nephrol 20:914\u2013919","journal-title":"Pediatr Nephrol"},{"key":"3041_CR45","first-page":"796","volume":"82","author":"X Chen","year":"2002","unstructured":"Chen X, Chen P, Cai G, Wu J, Cui Y, Zhang Y, Liu S, Tang L (2002) A randomized control trial of mycophenolate mofetil treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi 82:796\u2013801","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3041_CR46","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1523-1755.2005.00460.x","volume":"68","author":"S Tang","year":"2005","unstructured":"Tang S, Leung JCK, Chan LYY, Lui YH, Tang CSO, Kan CH, Ho YW, Lai KN (2005) Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int 68:802\u2013812","journal-title":"Kidney Int"},{"key":"3041_CR47","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","volume":"65","author":"BD Maes","year":"2004","unstructured":"Maes BD, Oyen R, Claes K, Evenepoel P, Kuypers D, Vanwalleghem J, Van Damme B, Vanrenterghem YFC (2004) Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int 65:1842\u20131849","journal-title":"Kidney Int"},{"key":"3041_CR48","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/ndt\/gfh974","volume":"20","author":"G Frisch","year":"2005","unstructured":"Frisch G, Lin J, Rosenstock J, Markowitz G, D\u2019Agati V, Radhakrishnan J, Preddie D, Grew J, Valeri A, Appel G (2005) Mycophenolate mofetil (MMF) vs. placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant 20:2139\u20132145","journal-title":"Nephrol Dial Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-3041-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-3041-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-3041-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T19:49:33Z","timestamp":1651520973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-3041-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3041"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-3041-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,15]]}}}